Overview

Evaluating of the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction

Status:
Completed
Trial end date:
2004-06-01
Target enrollment:
Participant gender:
Summary
Erectile dysfunction (ED) is defined as the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. An ideal treatment option should be effective and reliable, have minimal side effects, be simple to use and affordable. The purpose was the evaluation of efficacy and safety of 10 mg oral Vardenafil in Nigerian subjects with Erectile Dysfunction (ED).
Phase:
Phase 4
Details
Lead Sponsor:
Bayer
Collaborator:
GlaxoSmithKline
Treatments:
Vardenafil Dihydrochloride